|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.78 CHF | +0.69% |
|
+5.07% | -2.88% |
| 05-08 | Evonik core profit tops estimates as Iran conflict drives stockpiling | RE |
| 05-07 | DSM-Firmenich AG Approves Dividend, Payable on May 19, 2026 | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 14.7B | 5.54% | 8.9% | 5.21% | 3.4% | 1.48x | ||
| 371B | 18.03% | - | - | - | - | ||
| 65.33B | 6.29% | 9.93% | 10.66% | 4.83% | 0.24x | ||
| 33.57B | 4.88% | 7.62% | 10.7% | 3.8% | 0.87x | ||
| 36.87B | 5.87% | 7.1% | 8.43% | 5.17% | -0.65x | ||
| 24.28B | 13.39% | 23.45% | 75.22% | 8.38% | 0.95x | ||
| 16.04B | 19.11% | 26.28% | 93.75% | 19.64% | 1.76x | ||
| 34.22B | 3.24% | 10.86% | 5.91% | 1.94% | 1.15x | ||
| 5.1B | 23.12% | 15.38% | 11.34% | 10.03% | -2.05x | ||
| 10.64B | 4.19% | 8.89% | 5.59% | - | 0.74x | ||
| 13.71B | 0.38% | 5.37% | 2.07% | 2.27% | 2.3x | ||
| 14.22B | 4.13% | 5.85% | 13.2% | 3.77% | 3.47x | ||
| 23.1B | 4.72% | 25.1% | 19.41% | 4.58% | 14.37x | ||
| 5.25B | 11.68% | 16.63% | 7.4% | 3.71% | 6.68x | ||
| 3.07B | 12.86% | 18.3% | 19.8% | - | 1.7x | ||
| 19.36B | 10.13% | 11.96% | 14.81% | 6.7% | 1.02x | ||
| 21.36B | 4.67% | 11.44% | 11.82% | 3.04% | 1.08x | ||
| 4.41B | 8.69% | 17.39% | 19.22% | 9.95% | 0.65x | ||
| 2.42B | 13.29% | 13.73% | 8.4% | 3.71% | 5.56x | ||
| Average | 37.85B | 9.17% | 13.56% | 19.05% | 5.93% | 2.30x | |
| Weighted average by Cap. | 237B | 14.35% | 13.36% | 26.49% | 6.79% | 1.25x |
- Stock Market
- Equities
- DSFIR Stock
- Sector DSM-Firmenich
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















